Clinical Trial

A Study of KH607 as Monotherpy in Adults Participants With Major Depressive Disorder

Name: A Study of KH607 as Monotherpy in Adults Participants With Major Depressive Disorder — clinical trial record (NCT07741240)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This trial includes a short-term study and a long-term study. The short-term study is a multicenter, randomized, double-blind, placebo-controlled parallel-group study with a 6-week duration. The long-term study is a multicenter, open-label, single-arm study with a maximum duration of 27 weeks.

Trial Details

NCT Number	NCT07741240
Lead Sponsor	Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Conditions	Major Depressive Disorder (MDD)
Enrollment	232 participants
Start Date	2026-07
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-03